N A Holland1, D P Becak1, Jonathan H Shannahan2, J M Brown2, S A Carratt3, Lsv Winkle3, K E Pinkerton3, C M Wang4, P Munusamy4, Don R Baer4, S J Sumner5, T R Fennell5, R M Lust1, C J Wingard1. 1. Department of Physiology, Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA. 2. Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, USA. 3. Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California at Davis, Davis, California, USA. 4. Pacific Northwest National Laboratory, EMSL, Richland, USA. 5. RTI International, Discovery Sciences, Research Triangle Park, USA.
Abstract
BACKGROUND: Silver nanoparticles (AgNP) have garnered much interest due to their antimicrobial properties, becoming one of the most utilized nano-scale materials. However, any potential evocable cardiovascular injury associated with exposure has not been reported to date. We have previously demonstrated expansion of myocardial infarction after intratracheal (IT) instillation of carbon-based nanomaterials. We hypothesized pulmonary exposure to Ag core AgNP induces a measureable increase in circulating cytokines, expansion of cardiac ischemia-reperfusion (I/R) injury and is associated with depressed coronary constrictor and relaxation responses. Secondarily, we addressed the potential contribution of silver ion release on AgNP toxicity. METHODS: Male Sprague-Dawley rats were exposed to 200 μl of 1 mg/ml of 20 nm citrate-capped Ag core AgNP, 0.01, 0.1, 1 mg/ml Silver Acetate (AgAc), or a citrate vehicle by intratracheal (IT) instillation. One and 7 days following IT instillation the lungs were evaluated for inflammation and the presence of silver; serum was analyzed for concentrations of selected cytokines; cardiac I/R injury and coronary artery reactivity were assessed. RESULTS: AgNP instillation resulted in modest pulmonary inflammation with detection of silver in lung tissue and alveolar macrophages, elevation of serum cytokines: G-CSF, MIP-1α, IL-1β, IL-2, IL-6, IL-13, IL-10, IL-18, IL-17α, TNFα, and RANTES, expansion of I/R injury and depression of the coronary vessel reactivity at 1 day post IT compared to vehicle treated rats. Silver within lung tissue was persistent at 7 days post IT instillation and was associated with an elevation in cytokines: IL-2, IL-13, and TNFα and expansion of I/R injury. AgAc resulted in a concentration dependent infarct expansion and depressed vascular reactivity without marked pulmonary inflammation or serum cytokine response. CONCLUSIONS: Based on these data, IT instillation of AgNP increases circulating levels of several key cytokines, which may contribute to persistent expansion of I/R injury possibly through an impaired vascular responsiveness.
BACKGROUND: Silver nanoparticles (AgNP) have garnered much interest due to their antimicrobial properties, becoming one of the most utilized nano-scale materials. However, any potential evocable cardiovascular injury associated with exposure has not been reported to date. We have previously demonstrated expansion of myocardial infarction after intratracheal (IT) instillation of carbon-based nanomaterials. We hypothesized pulmonary exposure to Ag core AgNP induces a measureable increase in circulating cytokines, expansion of cardiac ischemia-reperfusion (I/R) injury and is associated with depressed coronary constrictor and relaxation responses. Secondarily, we addressed the potential contribution of silver ion release on AgNPtoxicity. METHODS: Male Sprague-Dawley rats were exposed to 200 μl of 1 mg/ml of 20 nm citrate-capped Ag core AgNP, 0.01, 0.1, 1 mg/ml Silver Acetate (AgAc), or a citrate vehicle by intratracheal (IT) instillation. One and 7 days following IT instillation the lungs were evaluated for inflammation and the presence of silver; serum was analyzed for concentrations of selected cytokines; cardiac I/R injury and coronary artery reactivity were assessed. RESULTS:AgNP instillation resulted in modest pulmonary inflammation with detection of silver in lung tissue and alveolar macrophages, elevation of serum cytokines: G-CSF, MIP-1α, IL-1β, IL-2, IL-6, IL-13, IL-10, IL-18, IL-17α, TNFα, and RANTES, expansion of I/R injury and depression of the coronary vessel reactivity at 1 day post IT compared to vehicle treated rats. Silver within lung tissue was persistent at 7 days post IT instillation and was associated with an elevation in cytokines: IL-2, IL-13, and TNFα and expansion of I/R injury. AgAc resulted in a concentration dependent infarct expansion and depressed vascular reactivity without marked pulmonary inflammation or serum cytokine response. CONCLUSIONS: Based on these data, IT instillation of AgNP increases circulating levels of several key cytokines, which may contribute to persistent expansion of I/R injury possibly through an impaired vascular responsiveness.
Authors: Pranita Katwa; Xiaojia Wang; Rakhee N Urankar; Ramakrishna Podila; Susana C Hilderbrand; Robert B Fick; Apparao M Rao; Pu Chun Ke; Christopher J Wingard; Jared M Brown Journal: Small Date: 2012-07-06 Impact factor: 13.281
Authors: Prabhakaran Munusamy; Chongmin Wang; Mark H Engelhard; Donald R Baer; Jordan N Smith; Chongxuan Liu; Vamsi Kodali; Brian D Thrall; Shu Chen; Alexandra E Porter; Mary P Ryan Journal: Biointerphases Date: 2015-09-15 Impact factor: 2.456
Authors: Xiang Wang; Tian Xia; Matthew C Duch; Zhaoxia Ji; Haiyuan Zhang; Ruibin Li; Bingbing Sun; Sijie Lin; Huan Meng; Yu-Pei Liao; Meiying Wang; Tze-Bin Song; Yang Yang; Mark C Hersam; André E Nel Journal: Nano Lett Date: 2012-05-04 Impact factor: 11.189
Authors: Achini K Vidanapathirana; Leslie C Thompson; Erin E Mann; Jillian T Odom; Nathan A Holland; Susan J Sumner; Li Han; Anita H Lewin; Timothy R Fennell; Jared M Brown; Christopher J Wingard Journal: Reprod Toxicol Date: 2014-08-01 Impact factor: 3.143
Authors: Jenny R Roberts; Walter McKinney; Hong Kan; Kristine Krajnak; David G Frazer; Treye A Thomas; Stacey Waugh; Allison Kenyon; Robert I MacCuspie; Vincent A Hackley; Vincent Castranova Journal: J Toxicol Environ Health A Date: 2013
Authors: Bey Fen Leo; Shu Chen; Yoshihiko Kyo; Karla-Luise Herpoldt; Nicholas J Terrill; Iain E Dunlop; David S McPhail; Milo S Shaffer; Stephan Schwander; Andrew Gow; Junfeng Zhang; Kian Fan Chung; Teresa D Tetley; Alexandra E Porter; Mary P Ryan Journal: Environ Sci Technol Date: 2013-09-18 Impact factor: 9.028
Authors: Nathan A Holland; Chad R Fraiser; Ruben C Sloan; Robert B Devlin; David A Brown; Christopher J Wingard Journal: Cardiovasc Toxicol Date: 2017-10 Impact factor: 3.231
Authors: Timothy R Fennell; Ninell P Mortensen; Sherry R Black; Rodney W Snyder; Keith E Levine; Eric Poitras; James M Harrington; Christopher J Wingard; Nathan A Holland; Wimal Pathmasiri; Susan C J Sumner Journal: J Appl Toxicol Date: 2016-10-03 Impact factor: 3.446
Authors: Nathan A Holland; Leslie C Thompson; Achini K Vidanapathirana; Rahkee N Urankar; Robert M Lust; Timothy R Fennell; Christopher J Wingard Journal: Part Fibre Toxicol Date: 2016-08-24 Impact factor: 9.400
Authors: Mohammad Javad Hajipour; Mehdi Mehrani; Seyed Hesameddin Abbasi; Ahmad Amin; Seyed Ebrahim Kassaian; Jessica C Garbern; Giulio Caracciolo; Steven Zanganeh; Mitra Chitsazan; Haniyeh Aghaverdi; Seyed Mehdi Kamali Shahri; Aliakbar Ashkarran; Mohammad Raoufi; Holly Bauser-Heaton; Jianyi Zhang; Jochen D Muehlschlegel; Anna Moore; Richard T Lee; Joseph C Wu; Vahid Serpooshan; Morteza Mahmoudi Journal: Chem Rev Date: 2019-09-06 Impact factor: 60.622